Piscataway, NJ, May 6, 2025 –Camber Pharmaceuticals is excited to announce the addition of Eslicarbazepine Acetate Tablets to its portfolio.
Eslicarbazepine Acetate Tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
Eslicarbazepine Acetate Tablets are available in:
- 200 mg, 400 mg and 800 mg strengths in 30-count bottles
- 600 mg strength in a 60-count bottle
To find out more information on Eslicarbazepine Acetate Tablets, please visit: www.camberpharma.com/eslicarbazepine
